$CNO

Bhojwani Gary C. sold $4.4M of CNO

Bhojwani Gary C. (Chief Executive Officer) sold 86,048 shares of CNO Financial Group, Inc. (CNO) at an average of $51.48 ($51.48–$51.48, $4.43M total) across 2 trades on 2026-06-30 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bhojwani Gary C.
Published Jul 1, 2026, 8:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 8:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CNO
Neutral
medium confidence
Mentioned
$CNO
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CNONeutralLow
01

Why it matters

The newest concrete fact is the CEO’s $4.43M open-market sale executed under a 10b5-1 plan; this can influence short-term sentiment but is less likely to change fundamentals immediately.

02

Market read

Traders may monitor for follow-on insider activity, but the 10b5-1 framing typically limits interpretive weight.

03

What to watch

The filing does not disclose reasons for the sale, and the CEO’s remaining holdings (174,264 shares after) may still indicate continued long-term exposure.

Relevance 5/10Novelty 5/10Timing: new Form 4 filed 2026-07-01 (covering 2026-06-30 sale)

Background

The article is a SEC Form 4 insider transaction disclosure for CNO Financial Group, Inc. (CNO).

Company-level read

Ticker impact

$CNONeutralMedium confidence
Context

CNO CEO Gary C. Bhojwani sold $4.43M of CNO shares in an open-market transaction under a pre-arranged 10b5-1 plan on 2026-06-30.

Expected impact

Likely limited immediate price impact; any effect is more sentiment/positioning than fundamentals.

Evidence & confidence

The filing is a primary-source Form 4 showing a sizable sale ($4.43M) while explicitly stating a pre-arranged 10b5-1 plan, which typically dampens interpretive value versus discretionary selling.

Market effects

Minimal; this is company-specific insider activity with no sector-wide regulatory or earnings signal.

None indicated; US-listed insurer insider transaction only.

None indicated; no cross-border deal, regulation, or macro linkage described.

Counterpoint

Because the sale is executed under a pre-arranged 10b5-1 plan, it may reflect routine liquidity/compensation rather than a bearish view on CNO’s prospects.

Key entities

  • CNO Financial Group, Inc.

    Subject of the Form 4 insider transaction; CEO sold 86,048 shares for ~$4.43M.

  • Gary C. Bhojwani

    CNO CEO and director who executed the open-market sale under a pre-arranged 10b5-1 plan.

Related articles

$CNOMed

CNO Financial posts insurance income gain on 16-quarter sales streak

CNO Financial Group reported Q2 2026 sales growth for a 16th consecutive quarter. Insurance policy income rose to $680.7 million from $651.3 million a year earlier, and net income increased to $125.9 million, or $1.33 per diluted share, from $91.8 million, or $0.91. CNO raised full-year 2026 operating EPS guidance by 8% at the midpoint and estimated RBC at 377% as of June 30.

$CNOMed

CNO Financial Group’s (NYSE:CNO) Q2 CY2026 Sales Beat Estimates

Insurance services company CNO Financial Group (NYSE: CNO) announced better-than-expected revenue in Q2 CY2026, with sales up 34.6% year on year to $1.29 billion. Its GAAP profit of $1.33 per share was 36.4% above analysts’ consensus estimates. Is now the time to buy CNO Financial Group? Find out by accessing our full research report, it’s free.

$CNOLow

CNO Financial Group, Inc. (CNO): Results of Operations and Financial Condition

CNO Financial Group, Inc. (CNO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 exhibit992-06302026investo.htm EX-99.2 Document Quarterly Financial Supplement - 2Q2026 July 30, 2026 Page 1 Table of Contents Page Consolidated balance sheet 3 Consolidated statement of operations 4 Financial summary 5 Insurance operations 6 Margin from insurance produ